| Dr Nancy Carolyn O'neal, MD | |
|
3932 Southview Ter, Medford, OR 97504-9367 | |
| (541) 261-1122 | |
| Not Available |
| Full Name | Dr Nancy Carolyn O'neal |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 33 Years |
| Location | 3932 Southview Ter, Medford, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669433991 | NPI | - | NPPES |
| 4898020 | Other | OR | BLUE CROSS |
| 241576 | Medicaid | OR | |
| 139572 | Other | OR | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD27835 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Asante Ashland Community Hospital | Ashland, OR | Hospital |
| Asante Rogue Regional Medical Center | Medford, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Asante Physician Partners | 8325206246 | 229 |
News Archive
The pharmaceuticalisation of sleep, put simply, refers to the ways in which sleep becomes a site for manipulation or augmentation through pharmaceutical use. There are different ways in which sleep can be pharmaceuticalised – for example we can use pharmaceuticals to induce sleep, to consolidate broken sleep, or to prevent or delay sleep.
Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced fiscal 2011 first quarter net revenues of $25.8 million and a net loss of $4.0 million, or $0.02 per share, which compares to net revenue of $26.4 million and a net loss of $4.6 million, or $0.03 per share for the same period in the fiscal 2010.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
Medtronic, Inc. has introduced at the American Association of Neurological Surgeons (AANS) meeting in Orlando the latest advancement in the company's line of Minimal Access Spinal Technologies (MASTSM), which offer surgeons the ability to treat conditions of the lumbar spine using less-invasive techniques.
From mollusks to mammals, newly discovered chemical pathways of serotonin in the nervous system are paving a path toward future pharmaceutical treatments for depression and other disorders.
› Verified 4 days ago
| Entity Name | Asante |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770587107 PECOS PAC ID: 0547177321 Enrollment ID: O20031219000238 |
News Archive
The pharmaceuticalisation of sleep, put simply, refers to the ways in which sleep becomes a site for manipulation or augmentation through pharmaceutical use. There are different ways in which sleep can be pharmaceuticalised – for example we can use pharmaceuticals to induce sleep, to consolidate broken sleep, or to prevent or delay sleep.
Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced fiscal 2011 first quarter net revenues of $25.8 million and a net loss of $4.0 million, or $0.02 per share, which compares to net revenue of $26.4 million and a net loss of $4.6 million, or $0.03 per share for the same period in the fiscal 2010.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
Medtronic, Inc. has introduced at the American Association of Neurological Surgeons (AANS) meeting in Orlando the latest advancement in the company's line of Minimal Access Spinal Technologies (MASTSM), which offer surgeons the ability to treat conditions of the lumbar spine using less-invasive techniques.
From mollusks to mammals, newly discovered chemical pathways of serotonin in the nervous system are paving a path toward future pharmaceutical treatments for depression and other disorders.
› Verified 4 days ago
| Entity Name | Asante Three Rivers Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801891809 PECOS PAC ID: 9931197993 Enrollment ID: O20040506000367 |
News Archive
The pharmaceuticalisation of sleep, put simply, refers to the ways in which sleep becomes a site for manipulation or augmentation through pharmaceutical use. There are different ways in which sleep can be pharmaceuticalised – for example we can use pharmaceuticals to induce sleep, to consolidate broken sleep, or to prevent or delay sleep.
Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced fiscal 2011 first quarter net revenues of $25.8 million and a net loss of $4.0 million, or $0.02 per share, which compares to net revenue of $26.4 million and a net loss of $4.6 million, or $0.03 per share for the same period in the fiscal 2010.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
Medtronic, Inc. has introduced at the American Association of Neurological Surgeons (AANS) meeting in Orlando the latest advancement in the company's line of Minimal Access Spinal Technologies (MASTSM), which offer surgeons the ability to treat conditions of the lumbar spine using less-invasive techniques.
From mollusks to mammals, newly discovered chemical pathways of serotonin in the nervous system are paving a path toward future pharmaceutical treatments for depression and other disorders.
› Verified 4 days ago
| Entity Name | Asante Physician Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922381326 PECOS PAC ID: 8325206246 Enrollment ID: O20120223000671 |
News Archive
The pharmaceuticalisation of sleep, put simply, refers to the ways in which sleep becomes a site for manipulation or augmentation through pharmaceutical use. There are different ways in which sleep can be pharmaceuticalised – for example we can use pharmaceuticals to induce sleep, to consolidate broken sleep, or to prevent or delay sleep.
Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced fiscal 2011 first quarter net revenues of $25.8 million and a net loss of $4.0 million, or $0.02 per share, which compares to net revenue of $26.4 million and a net loss of $4.6 million, or $0.03 per share for the same period in the fiscal 2010.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
Medtronic, Inc. has introduced at the American Association of Neurological Surgeons (AANS) meeting in Orlando the latest advancement in the company's line of Minimal Access Spinal Technologies (MASTSM), which offer surgeons the ability to treat conditions of the lumbar spine using less-invasive techniques.
From mollusks to mammals, newly discovered chemical pathways of serotonin in the nervous system are paving a path toward future pharmaceutical treatments for depression and other disorders.
› Verified 4 days ago
| Entity Name | Asante Ashland Community Hospital Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730628827 PECOS PAC ID: 7012286859 Enrollment ID: O20180426001620 |
News Archive
The pharmaceuticalisation of sleep, put simply, refers to the ways in which sleep becomes a site for manipulation or augmentation through pharmaceutical use. There are different ways in which sleep can be pharmaceuticalised – for example we can use pharmaceuticals to induce sleep, to consolidate broken sleep, or to prevent or delay sleep.
Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced fiscal 2011 first quarter net revenues of $25.8 million and a net loss of $4.0 million, or $0.02 per share, which compares to net revenue of $26.4 million and a net loss of $4.6 million, or $0.03 per share for the same period in the fiscal 2010.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
Medtronic, Inc. has introduced at the American Association of Neurological Surgeons (AANS) meeting in Orlando the latest advancement in the company's line of Minimal Access Spinal Technologies (MASTSM), which offer surgeons the ability to treat conditions of the lumbar spine using less-invasive techniques.
From mollusks to mammals, newly discovered chemical pathways of serotonin in the nervous system are paving a path toward future pharmaceutical treatments for depression and other disorders.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy Carolyn O'neal, MD 3932 Southview Ter, Medford, OR 97504-9367 Ph: (541) 261-1122 | Dr Nancy Carolyn O'neal, MD 3932 Southview Ter, Medford, OR 97504-9367 Ph: (541) 261-1122 |
News Archive
The pharmaceuticalisation of sleep, put simply, refers to the ways in which sleep becomes a site for manipulation or augmentation through pharmaceutical use. There are different ways in which sleep can be pharmaceuticalised – for example we can use pharmaceuticals to induce sleep, to consolidate broken sleep, or to prevent or delay sleep.
Arcadia Resources, Inc., a leading provider of innovative consumer health care services under the Arcadia HealthCare(SM) brand, today announced fiscal 2011 first quarter net revenues of $25.8 million and a net loss of $4.0 million, or $0.02 per share, which compares to net revenue of $26.4 million and a net loss of $4.6 million, or $0.03 per share for the same period in the fiscal 2010.
Teva Pharmaceutical Industries Ltd. today announced that new research data furthering the clinical understanding of its diverse multiple sclerosis (MS) treatment franchise will be presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Düsseldorf, Germany, September 9-12, 2009.
Medtronic, Inc. has introduced at the American Association of Neurological Surgeons (AANS) meeting in Orlando the latest advancement in the company's line of Minimal Access Spinal Technologies (MASTSM), which offer surgeons the ability to treat conditions of the lumbar spine using less-invasive techniques.
From mollusks to mammals, newly discovered chemical pathways of serotonin in the nervous system are paving a path toward future pharmaceutical treatments for depression and other disorders.
› Verified 4 days ago
Dr. Mark Adalbert Eaton, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Medical Center Dr, Ste 300, Medford, OR 97504 Phone: 541-282-6559 Fax: 541-282-6710 | |
Patrick Joseph Phelan, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Medical Center Dr, Ste 300, Medford, OR 97504 Phone: 541-930-8907 Fax: 541-245-4820 | |
Sandeep Singh Jhajj, M.D Surgery Medicare: Accepting Medicare Assignments Practice Location: 940 Royal Ave Unit 100, Medford, OR 97504 Phone: 541-732-8388 | |
Wie-peng Kuo, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1698 E Mcandrews Rd, Suite 160, Medford, OR 97504 Phone: 541-732-7874 Fax: 541-732-7875 | |
Dr. David Lee Street, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Medical Center Dr, Ste 300, Medford, OR 97504 Phone: 541-282-6559 Fax: 541-282-6710 | |
Dr. Mark C Mason, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1698 E Mcandrews Rd, Suite 160, Medford, OR 97504 Phone: 541-732-7874 Fax: 541-732-7875 | |
Dr. David Karl Traul, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 520 Medical Center Dr, Ste 300, Medford, OR 97504 Phone: 541-282-6559 Fax: 541-282-6710 |